Rationale and design of the ADVOR (Acetazolamide in Decompensated Heart Failure with Volume Overload) trial

European Journal of Heart Failure
Wilfried MullensMatthias Dupont

Abstract

Decisive evidence on the optimal diuretic agent, dosing schedule, and administration route is lacking in acute heart failure (AHF) with congestion. The Acetazolamide in Decompensated heart failure with Volume OveRload (ADVOR) trial is designed to test the hypothesis that the carbonic anhydrase inhibitor acetazolamide, a potent inhibitor of proximal tubular sodium reabsorption, improves decongestion when combined with loop diuretic therapy in AHF, potentially leading to better clinical outcomes. The ADVOR trial is set up as a multicentre, randomized, double-blind, placebo-controlled study, aiming to recruit 519 patients with AHF and clinically evident volume overload. All study participants receive high-dose intravenous loop diuretics as background therapy and are randomized towards intravenous acetazolamide at a dose of 500 mg once daily vs. placebo, stratified according to including study centre and ejection fraction (< 40% vs. ≥ 40%). The primary endpoint is successful decongestion with no more than trace oedema assessed on the third morning after hospital admission, with good diuretic efficacy defined as a urine output > 3.5 L during the first 30-48 h of decongestive treatment. Secondary endpoints include all-cause mortality...Continue Reading

References

Aug 1, 1994·British Heart Journal·D C Brater
Mar 1, 1997·Journal of Cardiovascular Pharmacology·H Knauf, E Mutschler
Oct 4, 2005·The American Journal of Cardiology·Mihai GheorghiadeGary S Francis
Nov 23, 2006·The American Journal of Medicine·Mihai GheorghiadeJohn Burnett
Dec 1, 2006·Journal of the American Society of Nephrology : JASN·Maki HasegawaYuichi Sugiyama
May 18, 2007·Heart Failure Reviews·Gerasimos Filippatos, Faiez Zannad
Aug 19, 2007·Heart·Arend Mosterd, Arno W Hoes
Feb 14, 2009·Journal of the American College of Cardiology·Mihai Gheorghiade, Peter S Pang
Oct 30, 2010·Journal of the American College of Cardiology·Jacob C JentzerAdrian F Hernandez
Mar 4, 2011·The New England Journal of Medicine·G Michael FelkerUNKNOWN NHLBI Heart Failure Clinical Research Network
Oct 11, 2011·Cardiology in Review·Rahim Kassamali, Domenic A Sica
Nov 26, 2011·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Hassane Amlal, Manoocher Soleimani
Feb 18, 2012·The Cochrane Database of Systematic Reviews·Rajaa F FarisAndrew J S Coats
Aug 1, 2012·Proceedings of the National Academy of Sciences of the United States of America·Manoocher SoleimaniHassane Amlal
Nov 8, 2012·The New England Journal of Medicine·Bradley A BartUNKNOWN Heart Failure Clinical Research Network
May 15, 2013·Diabetes, Obesity & Metabolism·H J Lambers HeerspinkJ List
Jun 12, 2013·Journal of the American College of Cardiology·Frederik H VerbruggeWilfried Mullens
Sep 28, 2013·European Journal of Internal Medicine·João Pedro FerreiraHenrique Carvalho
Dec 18, 2013·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Yu AnXue-jun Li
Jan 28, 2014·European Journal of Heart Failure·Frederik H VerbruggeWilfried Mullens
Apr 11, 2014·The New England Journal of Medicine·Bertram PittUNKNOWN TOPCAT Investigators
Jun 18, 2014·The American Journal of Medicine·Muthiah VaduganathanMihai Gheorghiade
Jul 20, 2014·Circulation. Heart Failure·Frederik H VerbruggeWilfried Mullens
Feb 11, 2015·Journal of the American College of Cardiology·Frederik H VerbruggeWilfried Mullens
Feb 3, 2016·The American Journal of Medicine·Frederik H VerbruggeW H Wilson Tang
Jan 21, 2017·European Journal of Heart Failure·Jozine M Ter MaatenJeffrey M Testani
Mar 23, 2017·European Heart Journal·Wilfried MullensWai Hong Wilson Tang
Jul 13, 2017·JAMA Cardiology·Javed ButlerUNKNOWN National Heart Lung and Blood Institute Heart Failure Clinical Research Network
Oct 2, 2017·Clinical Drug Investigation·Tomasz Imiela, Andrzej Budaj
Nov 16, 2017·The New England Journal of Medicine·David H Ellison, G Michael Felker
Dec 19, 2017·European Journal of Heart Failure·Lucas N L Van AelstMarie-France Seronde

❮ Previous
Next ❯

Citations

Feb 15, 2019·Current Heart Failure Reports·Richa GuptaSean Collins
Aug 8, 2019·European Journal of Heart Failure·Jozine M Ter Maaten, Kevin Damman
Mar 9, 2019·Cardiac Failure Review·Marco MetraNicolò Dasseni
Nov 9, 2019·Heart Failure Reviews·Gaetano RuoccoJozine M Ter Maaten
Dec 28, 2019·Current Pharmaceutical Design·Carmelo ButtàAntonio Pinto
May 11, 2019·European Journal of Heart Failure·Frederik H VerbruggeWilfried Mullens
Aug 31, 2019·European Journal of Heart Failure·Andrew J Stewart Coats
Jan 31, 2020·ESC Heart Failure·Daniela TomasoniMarco Metra
Jul 22, 2019·Heart Failure Reviews·Pierpaolo PellicoriJohn G F Cleland
Nov 21, 2019·European Journal of Heart Failure·Marianna AdamoMarco Metra
May 18, 2020·Nature Reviews. Cardiology·Eva M BoorsmaAdriaan A Voors
Sep 11, 2020·Current Cardiology Reports·W H Wilson Tang, Alan Kiang
Sep 15, 2019·Heart Failure Reviews·Zachary L Cox, Jeffrey M Testani
Mar 16, 2019·Journal of Clinical Medicine·Janewit WongboonsinWisit Cheungpasitporn
Aug 11, 2020·Cardiology and Therapy·Joseph J CuthbertAndrew L Clark
Oct 13, 2020·Cardiac Failure Review·Ingibjörg KristjánsdóttirLars H Lund
Dec 6, 2020·ESC Heart Failure·Daniela TomasoniMarco Metra
Feb 10, 2021·Expert Opinion on Pharmacotherapy·Bharat NarasimhanWilbert S Aronow
Feb 19, 2021·Hospital Practice·Steven G Chrysant, George S Chrysant
Feb 24, 2021·European Heart Journal. Acute Cardiovascular Care·Gregorio TersalviWilfried Mullens
Mar 13, 2021·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Saif AliDmitry Abramov
Mar 14, 2020·Journal of the American College of Cardiology·G Michael FelkerJeffrey M Testani
Aug 28, 2021·European Heart Journal·Theresa A McDonaghUNKNOWN ESC Scientific Document Group
Sep 17, 2021·European Heart Journal·Pieter MartensWilfried Mullens

❮ Previous
Next ❯

Related Concepts

Related Feeds

Argentine Hemorrhagic Fever

Argentine hemorrhagic fever (AHF) is an endemo-epidemic disease caused by junín virus (JUNV), a member of the arenaviridae family. Discover the latest research on AHF here.